NCT01235728 A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) Status COMPLETED Phase PHASE1
NCT01235442 Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01233583 Regulatory T-cells in Psoriasis Patients as Targets for Therapy Status COMPLETED Phase N/A
NCT01229085 Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis Status COMPLETED Phase PHASE3
NCT01228409 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Status UNKNOWN Phase PHASE4
NCT01225731 A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003) Status COMPLETED Phase PHASE2
NCT01223976 Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis Status UNKNOWN Phase PHASE4
NCT01208090 ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01206660 Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01206387 Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01205880 Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT01187264 Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis Status COMPLETED Phase PHASE4
NCT01186744 A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea Status COMPLETED Phase PHASE4
NCT01177800 A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT01169987 Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life Status COMPLETED Phase N/A
NCT01163253 A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis Status TERMINATED Phase PHASE3
NCT01155570 Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation) Status COMPLETED Phase N/A